EX-16.1 2 ea020214801ex16-1_cordyceps.htm LETTER FROM KCCW ACCOUNTANCY CORP. ADDRESSED TO THE U.S. SECURITIES AND EXCHANGE COMMISSION

Exhibit 16.1

 

  Audit ● Tax ● Consulting ● Financial Advisory
Registered with Public Company Accounting Oversight Board (PCAOB)

 

March 18, 2024

 

Securities and Exchange Commission

Office of the Chief Accountant

100 F Street, NE

Washington, D.C. 20549

 

Re: Cordyceps Sunshine Biotech Holdings Co., Ltd.

 

Dear Sir or Madam:

 

We have read the statements made by Cordyceps Sunshine Biotech Holdings Co., Ltd. of its Form 6-K dated March 18, 2024. We agree with the statements concerning our firm in such Form 6-K; we are not in a position to agree or disagree with other statements of Cordyceps Sunshine Biotech Holdings Co., Ltd. contained therein.

 

Very truly yours,   
    
/s/ KCCW Accountancy Corp       
   
Diamond Bar, CA